60
Participants
Start Date
October 16, 2023
Primary Completion Date
April 1, 2025
Study Completion Date
April 1, 2025
Dasatinib 70 mg
Commercially available tablets containing 50 and 20 mg of dasatinib will be used. The tablets will be re-capsulated to keep the study blind
Placebo
Maltodextrin capsules with identical size and appearance (shape, size, colour and flavour) as the dasatinib-containing capsules.
Hospital Universitari Germans Trias i Pujol, Badalona
Spanish Clinical Research Network - SCReN
NETWORK
IrsiCaixa
OTHER
University of Turin, Italy
OTHER
Instituto de Salud Carlos III
OTHER_GOV
Germans Trias i Pujol Hospital
OTHER
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
OTHER
Fundació Institut Germans Trias i Pujol
OTHER